Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
adch3nsmut1 (1 trial)
mva-nsmut (1 trial)
Hepatitis (Phase 1)
Hepatitis A (Phase 1)
Hepatitis C (Phase 1)
Infections (Phase 1)
Trials (1 total)
Trial APIs (2 total)